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ABSTRACT
Introduction Stroke survivors, once in the community,
face challenges with their long-term rehabilitation care
and present higher levels of loneliness, depression and
anxiety than the rest of the population. A community-
based performance arts programme, Stroke Odysseys
(SO), has been devised to tackle the challenges of living
with stroke in the UK. In this study, we aim to evaluate the
implementation, impact and experiences of SO for stroke
survivors.
Methods and analysis Scaling-up Health Arts
Programmes: Implementation and Effectiveness Research
(SHAPER)-SO aims to scale-up SO to 75 participants and
47 stakeholders, while simultaneously evaluating the
effectiveness and implementation of the programme. The
main research aim is to evaluate the implementation,
effectiveness, impact and experiences of a community-
based performance arts programme (SO for stroke
survivors). This mixed-methods study will evaluate the
experience and impact of SO on those participating using
mixed methods (interviews, observations and surveys)
before and after each stage and carry out non-participant
observations during a percentage of the workshops,
training and tour. Data will be analysed using quantitative
and qualitative approaches. This is a study within the
SHAPER programme.
Ethics and dissemination Ethical approval has been
granted by the King’s College London PNM Research
Ethics Panel, REC reference: LRS/DP-20/21–21549.
Written informed consent will be sought for participants
and stakeholders. The results of the study will be reported
and disseminated at international conferences and in peer-
reviewed scientific journals.
Trial registration number NCT04864470.

INTRODUCTION
Stroke affects over 113 000 people every
year1 and, according to the latest statistics,
there are currently more than 1.2 million
stroke survivors in the UK.2 3 The effects of

Strengths and limitations of this study
► The first study examining an art intervention on

stroke survivors, using a type 2 hybrid design, with
a dual focus on effectiveness and implementation
outcomes.
► The unique study design will result in a package of
clinical and implementation data on this particular
intervention.
► There may be inconsistency in participant experience throughout an intervention period if in-person
sessions are switched online and vice versa due to
COVID-19 social distancing restrictions.
► Access to the COVID-19-adapted online delivery of
Stroke Odysseys may be challenging for people with
severe acquired brain injury, resulting from stroke.

stroke are often devastating, with almost two-
thirds of survivors leaving the hospital with a
disability and half experiencing depression
within 5 years.4 5 In addition to the substantial
impact, stroke has on those affected and their
caregivers, it can also pose a significant financial burden to health and social care services.
The societal cost of stroke has been estimated
to be £26 billion per annum, with National
Health Service (NHS) costs accounting for
£3.4 billion in 2015, and projected to increase
to £10.2 billion by 2035.6
Stroke survivors commonly face emotional,
social and psychological challenges, with
depression, anxiety and apathy being the most
prevalent neuropsychiatric sequelae.7 Such
disabling symptoms are often coupled with
feelings of abandonment8 once hospital rehabilitation ends and their recovery plateaus.
Stroke survivors in the UK usually receive
rehabilitation while in hospital but once they
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AIMS AND OBJECTIVES
The three main objectives in this study are: (1) to explore
the clinical impact (effectiveness) of SO on stroke survivors; (2) to explore SO implementation aspects including
uptake, adoption, perceived acceptability, appropriateness, feasibility, the fidelity of receipt, unintended
consequences and sustainability and (3) to evaluate
implementation costs and cost-effectiveness of the intervention, with focus on the costs associated with implementing SO into existing care pathways, health services,
partner organisations and commissioning and the impact
of scaling up SO on the utilisation of health services.
The main research aim is to evaluate the implementation, effectiveness, impact and experiences of a
community-based performance arts programme (SO for
stroke survivors).
Our study objectives are as follows:
1. To explore the impact of participation in performance
programmes on cognitive health and physical, psychological and social well-being of people who have experienced stroke.
2. To study the context, mechanisms of delivery and interactions between participants and facilitators which
take place during SO delivery.

2
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Stroke Odysseys
Rosetta Life, a well-established non-profit organisation
with a track record of conducting arts programmes
for stroke and brain injury survivors, developed SO, a
performance-
based arts programme with continued
consultation from stakeholders (including stroke survivors). SO provides an opportunity for those who have had
a stroke or brain injury to share their experiences with
an audience through movement, music, songwriting and
the spoken word. The programme, which has now been
running for over 21 years, uses performance arts to help
stroke survivors overcome psychological challenges such
as lowered self-esteem, anxiety and depression, which are
commonly reported by individuals.16
In this protocol paper, we present our plans to evaluate. SHAPER-SO will be a two-pronged study, examining
the implementation and clinical effectiveness of SO.
The research we will be undertaking examines both, the
impact of performance arts on participants and how SO
can be embedded into clinical pathways. This will help
us to identify not just ‘if’ but also ‘why’ the programme
works and support our understanding of how it can be
successfully delivered and scaled up within clinical pathways. Alongside this, we will examine participants’ experiences of the programme using an ethnographic and
constructivist approach. To the best of our knowledge,
SHAPER-SO is the first study of its kind in the context of
stroke care and rehabilitation.
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Clinical Commissioning Groups (CCGs), ensuring the
long-term sustainability of delivery.15

are discharged, the level of support in the community
tends to be variable and in the long-term, inadequate
for their needs.8 This is consistent with a meta-review of
qualitative systematic reviews,9 which reported a lack of
self-
management resources available following stroke,
highlighting the gap between available services and the
long-term social, emotional and physical needs of stroke
survivors throughout their rehabilitation journey.10 Additionally, the findings of a survey by the Stroke Association in the UK emphasised the devastating burden and
‘hidden effects’ of stroke.11 The survey, which collated
data from over 10 000 stroke survivors and is the biggest
to date in the UK, revealed that the effects of stroke on
cognition, emotions, relationships and mental health are
widespread, can be life-long and are often overlooked
or neglected. In the survey, 50% of stroke survivors and
85% of caregivers reported a gap between the support
provided versus the support they felt was needed. While
current stroke rehabilitation targets functional recovery,
it fails to meet the psychosocial needs of stroke survivors.
The evidence summarised above suggests that there is a
need for more holistic rehabilitation programmes, especially non-pharmacological and non-invasive modalities,
to address the psychosocial needs and improve the quality
of life of stroke survivors.12 Arts-based programmes (such
as ‘Stroke Odysseys (SO)’ discussed below) are one such
approach that shows promising results in enhancing the
well-being, self-esteem, social life and rehabilitation experiences of patients with stroke.13 Indeed, over the past
decade, several studies conducted in this patient population have consistently shown a positive impact of different
art modalities on psychological (eg, enhancement in
confidence and a better sense of control), social (eg,
increased social interactions and peer support) and functional (eg, improvement in physical abilities) outcomes.12
Nonetheless, despite the growing body of research on
the benefits of art interventions, the process of scaling-up
these interventions, embedding them into healthcare
and its associated challenges are not yet well established.
Preliminary data indicate that SO (discussed below) is
received positively by those who take part,14 however,
identifying barriers to implementation and exploring
ways to overcome these obstacles are essential to successfully and sustainably embed SO into clinical pathways and
roll out the programme at a wider scale.
SO is part of the Scaling-up Health Arts Programme:
Implementation and Effectiveness Research (SHAPER),
which is, to our knowledge, the world’s largest study on
arts and health examining both clinical effectiveness and
implementation effectiveness of three community-based
arts programmes: Melodies for Mums (M4M), a singing
intervention for postnatal depression, PD-Ballet, a dance
intervention for Parkinson’s Disease and SO. Overall,
SHAPER has three primary aims: (1) to successfully
embed each of the art interventions into the healthcare
system (ie, taking a social prescribing approach), (2)
to scale up these interventions at a larger scale and (3)
to facilitate these interventions being commissioned by

Open access
together with Proctor et al’s23 taxonomy of implementation outcomes, guided our choice of implementation
measures to assess.
METHODS AND ANALYSIS
Design
SHAPER-
SO is a mixed-
methods programme study,
comprising quantitative and qualitative methods to assess
the clinical and implementation outcomes outlined in
the measures section below.

THEORETICAL UNDERPINNING
An ethnographic and constructivist approach will be
used to examine stroke survivors’ experiences of the SO
programme (objective 2). This is described as the study
of social interactions, behaviours and perceptions that
occurs within groups, team organisation and communities. Ethnography provides rich, holistic insights
into people’s views and actions as well as the nature of
the location (context) they inhabit. The aim has been
described as ‘getting inside’ the way each group of people
sees the world.17 Ethnography has a strong emphasis on
‘unstructured data and involves implicit interpretation of
the meaning and function of human interactions, rather
than hypothesis testing. This approach aligns well with
the complex nature of the SO programme.
The implementation analyses are informed by several
well-
established implementation science frameworks,
which we have applied to develop a set of implementation facets of SO to assess, both quantitatively and
qualitatively (see the Methods). We used the recently
developed ‘Implementation Science Research Development’ (ImpRes) framework17 to identify the elements of
implementation that the study ought to capture, ImpRes
defined 10 different domains that an implementation
evaluation ought to capture—including capturing stakeholder engagement, the outcome of implementation
(eg, how acceptable, appropriate and feasible SO and
its implementation processes are to those delivering and
also receiving SO) and any unintended consequences
(objective 3, 5 and 6). Moreover, we reviewed the Capability, Opportunity and Motivation Model of Behaviour
(COM-B) tool18 to help us identify any barriers that
may affect an individual’s engagement with the SO
programme (objectives 7 and 10). The COM-B components lie at the centre of the Behaviour Change Wheel,
a framework for designing and characterising behaviour
change interventions.18 The Consolidated Framework for
Implementation Research (CFIR)19 20 will help us map
reported barriers and drivers to the implementation of
the SO (objective 7); and finally, the Reach Effectiveness
Adoption Implementation Maintenance model21 22 taken

Intervention
SO is a poststroke performance art intervention designed
and delivered by the arts organisation Rosetta Life. This
intervention initially developed and funded by King’s and
Guy’s & St Thomas’ Charity, aims to improve recovery,
agency and well-being after stroke.14
SO comprises three distinct stages (1) weekly workshops conducted over 12 weeks for stroke participants
which will be facilitated by an integrated team of expert
artists and ‘stroke ambassadors’ from the charity Rosetta
Life, (2) a smaller group of ambassadors recruited from
the workshops will be trained to become cofacilitators
(ie, new stroke ambassadors), (3) a performance tour
including education and taster workshops for audiences.
During sessions, which run for 3 hours each, participants
devise a dance and music performance work from their
own stories. The practice of ‘performing ourselves’ is key
to achieving successful outcomes such as transforming
the participants’ perception of identity. The culmination
of the programme will be a public-facing performance to
an audience of carers, healthcare practitioners, friends,
family and the wider community.
19 pandemic and the
Due to the ongoing COVID-
necessity of shielding vulnerable adults and foreseeing
increased anxiety in stroke survivors to attend in-person
sessions, we have adapted the SO programme to be delivered through a mixture of live/face-to-face and online
delivery (blended approach). Participants will be able to
choose whether to attend the sessions/participate face-to-
face or online based on their personal preferences and
needs. The researcher will manage groups to ensure that
all the participants who wish to attend in person will be
able to do so during the 12 weeks.
The adapted programme will still be run in three stages,
described below:
Stage (1): the workshops are the result of cocreation;
the general framework is: weeks 1–3 building the performance company, weeks 4–6 devising the performance
weeks 6–9 rehearsing the performance and weeks 10–12
are sometimes concertinaed into one production week
introducing stage management, lighting and technical
runs. Each of the 12 workshops contains a performance
‘class’ of 20–30 mins exploring movement and voice techniques and exercise.
Participants will be able to choose whether to attend
the sessions/participate face-to-face or online based on
their personal preferences and needs.
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3. To explore the learning and experiences of facilitators
and participants after SO delivery.
4. To evaluate any change in the emotional well-being,
participation and activity of stroke participants pre-SO
and post-SO.
5. To evaluate the extent to which SO is acceptable, feasible to undertake and appropriate to survivors and wider stakeholders (including ambassadors, artists, and
clinician referrers to the programme).
6. To explore the challenges, barriers, facilitators and unintended consequences of the implementation of SO.
7. To assess the costs associated with the implementation
of the programme.
8. To assess the adoption, adherence to it and attrition
rates of the programme.

Open access
Sample and recruitment
Stroke survivors
Consenting stroke participants will be included if they
are:
1. over 18 years of age,
2. have had one or more stroke(s),
3. received inpatient care in a UK stroke care pathway,
4. able to follow a two-stage command and hold a conversation in English if no supporter/friend is available to
translate.
The following exclusion criteria will be applied to
individuals:
1. with comorbidities that would prevent participation in
group activities (eg, dementia or deteriorating or fluctuating palliative conditions),
2. unable to understand English,
3. unable to commit to the 12-week programme.
Additionally, stroke ambassadors will be included if
they have been through the ambassador training and are
involved in at least one programme cycle culminating in
the tour.
All participants will be offered the option of completing
an interview with their carer present. This will be offered
both after the first 12-week programme and after the
ambassador training, for those that wish to participate.
Those that decline will be asked if they would be willing
to provide their reasons why.
Wider stakeholder group
In addition to the stroke survivors that enrol on the SO
programme, data will also be collected from a wider stakeholder group involved in the delivery or support of the
programme. Individuals will be recruited if they meet the
following criteria:
► over 18 years of age,
► can hold a conversation in English if no supporter/
friend is available to translate,
► can either be defined as a:
– Supporters: family members or carers.
– Deliverers: individuals responsible for the delivery
of the research (facilitators and artists).
– Referrers: individuals involved in signposting (eg,
doctors, nurses, healthcare workers).
Wider stakeholders will be excluded from participation if they are unable to understand English or if no
supporter/friend is available to translate.

Study setting
The study will take place online until conditions of the
pandemic enable researchers, artists and participants to
meet safely indoors, as per government guidelines. When
it is feasible and safe to meet in person, participants,
artists and researchers will meet in an established performance arts education centre to ensure that COVID-19
guidelines on cleanliness are guaranteed. When ran in
person, the workshops are run in Central London locations, with a single centre running the programme in
each cycle.

Sampling
Sample size
We aim to recruit 75 new stroke survivors in total for the
duration of the study. A prediction of 75 participants has
been estimated based on the numbers that over the years
running SO, Rosetta Life has been able to recruit in two
consecutive cycles. This number has also considered the
organisation being able to while maintain a manageable
ratio of participants to artists and staff members, guaranteeing that SO is delivered to the highest standard.

4
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Stage (2): after the performance is completed, participants will be invited to a 4-day training programme where
they will learn to act as advocates for life after stroke—
termed ‘stroke ambassadors’. The optional ambassador
training starts with an introduction to being an ambassador and an outline of the pathways available: (a)
supporting artists in hospital and community contexts,
(b) speaking the press and media/advocating for life
after stroke, (c) engaging in academic research and (d)
joining the steering group that informs activities and
directions.
The skill development training is delivered in three
stages: an introduction to movement practices and the
traditions of independent dance, then an introduction to
voice and improvisation and, finally, an introduction to
performance. Each ambassador then constructs an individually tailored programme according to their personal
goals and intentions in becoming an ambassador.
The programme will take place once weekly and will
be led by a team of artists and supported by a leadership
coach. All training will take place on Zoom until social
distancing measures are lifted, and participants are
willing to meet indoors—a blended ambassador training
will be offered.
Stage (3): following training, a volunteer manager
will coordinate a tailored programme where ambassadors support artists in recruitment, befriend the newly
discharged stroke survivors and take part in small-scale
performance tours to challenge the perception of
disability. The tour will be delivered online with online
screenings followed by a question and answers (Q&A)
session with ambassadors, taster sessions and exercises
delivered online with the ambassadors.
The programme will be delivered in two cycles of the
complete three-stage intervention. At the end of the two
cycles of the programme, a group of newly trained ambassadors will emerge. The programme seeks to develop a
national network of ambassadors who will build capacity
for performance arts in healthcare and a wider capacity
for healthcare. The stroke ambassadors are graduates of
the 12-week workshop that receive training, based on a
leadership-coaching model, and they deliver a tailored
advocacy programme according to their creative skills—
befriending, performance administration and support,
programme advocacy.

Open access

Recruitment procedure
Potential stroke survivor participants will be identified
through signposting in community centres and care
homes as well as engaging in presentations, screenings,
taster sessions and performances during the tour.
Recruitment of potential participants will be done
online. Screenings of performance extracts will be
followed by taster sessions online and a Q&A with
ambassadors. Potential participants will be directed to
the project manager at Rosetta Life who will manage all
referrals.
Potential participants will be offered a Participant
Information Sheet (PIS) and an Informed Consent
Form (ICF) and will be explained the details of the
study. Written consent will be sought following a 48 hours
colling-off period.
Wider stakeholders will be recruited from the networks
of people involved in the referral, delivery or support of
the programme.
A recruitment log will be kept by the research team to
accurately record included and excluded participants as
well as missing data from dropouts to account for possible
sampling bias.
Study flowchart
A study overview is seen in the flowchart below (figure 1):
Data collection
This is a prospective mixed-methods study using a range
of qualitative and quantitative methods at different
time points pre, during and postintervention of each
programme cycle.
Qualitative methods will comprise semistructured interviews and non-participant observations of training and
production to assess experiences and attitudes towards
the programme and its implementation.
Quantitative methods will be used to assess experiences
and attitudes towards the SO programme and its implementation. Further information is included further in
the ‘methods’ section in the outcome measures tables
(tables 1 and 2) and the ‘assessment descriptions’ section.
Demographic data will be collected by Rosetta Life at
the time of enrolment.
Estevao C, et al. BMJ Open 2022;12:e057805. doi:10.1136/bmjopen-2021-057805

Figure 1 SHAPER-SO study flowchart. Scaling-up Health
Arts Programmes: Implementation and Effectiveness
Research-Stroke Odysseys.

Outcomes
Data on the clinical outcomes will be collected from
stroke survivors who have enrolled on the SO programme
(see table 1). Data on the implementation outcomes will
be collected from stroke survivors who have enrolled on
the SO programme as well as the wider stakeholder group
involved in the SO programme, including deliverers,
referrers and supporters (see table 2).
Time points for data collection: T0—baseline; T1—
midway through the 12-week programme (weeks 5–7);
T2—immediately
postperformance
(12–14 weeks);
T3—immediately after the advocacy training for stroke
ambassadors.
To maximise inclusivity and outcome completion, and
minimise participant burden, outcome assessments, where
possible, will be conducted either face-to-face, online, by
telephone or via postal questionnaire depending on the
outcome measures being assessed, participants’ preferences and government COVID-19 guidelines.
Assessment descriptions for clinical outcomes
Qualitative assessments
Ethnographic research
Ethnographic non-participant observations of a selection
of the 12 workshops including at least 1–2 groups from
each of the two phases (building confidence, rehearsal
and production) to capture facilitator and participant
practice, interactions and routines. Each observation
period will last for the duration of the workshop, and
the ethnographic researcher will record field notes
contemporaneously.
Semistructured interviews
Semistructured interviews will be held with facilitators
and participants’ pre and postprogramme cycles to
explore anticipated concerns and expectations (pre)
5
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Based on previous experience of running SO where
participants then complete an ambassador training
cycle, a drop-out rate of 20% is expected, and so the final
number of ambassadors that complete the ambassador
training is estimated to be 60.
The wider stakeholder group will be recruited from the
network of people who are involved in the programme
and present in the community. This includes the voluntary sector, health and social care sectors and clinical
commissioners. A total of 47 stakeholders, a forecast
based on the existing network numbers, will be recruited
(12 carers, 10 clinical team members, 5 artists, 20 existing
ambassadors).

Open access

Objective

Clinical outcome measures/
endpoints

Type of assessment

The time point for data collection

Qualitative

T1 (during workshop delivery)

Primary objective
Secondary objectives
To study the context,
mechanisms and interactions
which take place during SO
delivery

Non-participant observations of
workshops

To explore the learning and
experiences of facilitators and
participants

Semi-structured interviewsQualitative
stroke participants and facilitators

To explore stroke survivors’
Semi-structured interviewspreparation and participation in stroke participants
performances

Qualitative

T2

T0

Data on the clinical outcomes will be collected from stroke survivors who have enrolled on the SO programme.
SO, Stroke Odysseys.

and experiences of facilitation and factors influencing
delivery, engagement of participants, adaptation and
learning (post).
The implementation science research team will be
interviewing participants across both, the 12-
week
programme and ambassador training, in addition to
wider stakeholders.
Assessment descriptions for the implementation outcomes
Quantitative assessments
Validated and standardised implementation scales will
be used to gather quantitative data on how acceptable,
appropriate and feasible the SO programme is perceived
by stroke survivors, ambassadors, deliverers, supporters
and referrers. These scales include the Acceptability of
Programme Measure (AIM), the Programme Appropriateness Measure (IAM) and the Feasibility of Programme
Measure (FIM). For further information on the development of these scales, please refer to the paper by Weiner
et al.24
The implementation science researchers will quantify and cost the resources used in implementing the
programme, evaluate wider service utilisation and associated costs before and after participants complete the
programme, including any changes to their quality-of-life
profile measured using the EQ5D-3L preference-based
QoL measure. The EQ5D-3L is a self-complete multiattribute measure of health-related quality of life that assigns
individuals a unique state of health based on their response
to individual items. Each unique health state is associated
with a predetermined ‘utility’ value derived from a survey
of wider community preferences over different states of
health. The utility scale is anchored at 1 (full health) and
zero (death), with negative values allowed in instances
where states of health are considered worse than death.
Health state utility values are subsequently used to estimate quality-adjusted life years (QALYs) survived over
time—the utility scores providing the means of making
the quality adjustments. Evidence on costs and QALYs will
6

subsequently be used to inform an analysis of the cost-
effectiveness of programme delivery at scale.
Qualitative data collection
Semistructured interviews
Semistructured interviews will be conducted with a
purposive subsample of stroke survivors (N=20: 5 from
each cycle at two time points—T2 and T3). Interviews will
be carried out with this subsample of stroke survivors to
explore their attitudes towards the acceptability, appropriateness and feasibility of the programme as well as factors
(facilitators or barriers) that affected their involvement
(and potential drop-
out) and any unintended consequences. These issues will also be explored with a subsample of individuals (10 in total) from each of the wider
stakeholder groups.
Interview guides have been based on the existing implementation frameworks (see above) and adapted from a
previous project.25 They will be further adapted and codesigned with our stakeholder group to ensure the questions in the interview guide are meaningful and address
the core aims of the study.
Interviews will be audiotaped and are anticipated to
be conducted 1:1 or in participants dyads, face to face
(government guidelines permitting) or remotely by
phone or video.
Data analysis
Data will be analysed using quantitative and qualitative
approaches.
Quantitative analysis
Descriptive statistics of survey data will be performed
(frequency distribution, central tendency). Parametric
and non-
parametric tests will also be employed to
compare the survey responses to the AIM, FIM, IAM and
EQ5D before and after the SO intervention. Changes in
AIM, FIM, IAM and EQ5D will be assessed using generalised linear models depending on the distribution of the
Estevao C, et al. BMJ Open 2022;12:e057805. doi:10.1136/bmjopen-2021-057805
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Table 1 Clinical outcomes
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Implementation outcome measures/
endpoints

Type of
assessment

Time points for
data collection

Who data will be collected
from

Acceptability of intervention Measure
Semi-structured interviews (to explore
reasons for acceptability score)

Quantitative
Qualitative

T1, T2, T3
T2, T3

Stroke survivors, deliverers,
supporters, referrers
Stroke survivors, deliverers,
supporters, referrers

To evaluate to what extent SO are
appropriate to survivors and wider
stakeholders

Intervention Appropriateness Measure
Semi-structured interviews (to explore
reasons for appropriateness score)

Quantitative
Qualitative

T1, T2, T3
T2, T3

Stroke survivors, deliverers,
supporters, referrers
Stroke survivors, deliverers,
supporters, referrers

To evaluate to what extent Stroke
Odysseys feasible to survivors and
wider stakeholders

Feasibility Intervention Measure
Semi-structured interviews (to explore
reasons for feasibility score)

Quantitative
Qualitative

T1, T2, T3
T2, T3

Stroke survivors, deliverers,
supporters, referrers
Stroke survivors, deliverers,
supporters, referrers

To assess any unintended
consequences of the programme

Semi-structured interviews

Qualitative

T2, T3

Stroke survivors, deliverers,
supporters, referrers

To explore the facilitators and barriers to Semi-structured interviews
implementing the programme

Qualitative

T2, T3

Stroke survivors, deliverers,
supporters, referrers

To explore the facilitators and barriers to Semi-structured interviews
sustained use of the programme

Qualitative

T2, T3

Stroke survivors, deliverers,
supporters, referrers

Objective
Primary objective
To evaluate to what extent SO is
acceptable, to survivors and wider
stakeholders
Secondary objectives

To assess service utilisation and
cost associated costs and changes
in quality of life associated with the
implementation of the programme

EQ5D-5L (quality of life measure) and
Quantitative
AD-SUS (adult service receipt schedule)
and semi-structured interviews and
activity data (to estimate implementation
costs).

T2 and T3

Stroke survivors
Stroke survivors, deliverers,
supporters, referrers

To explore the strategies including
resource inputs used, used within
individual sites to implement the
programme

Semi-structured interviews

Qualitative

T2, T3

Deliverers, referrers

To assess the adoption of the
programme

The number of individuals delivering
the programme, and the number of
individuals supporting the programme
(and continuing to do so)

Quantitative

T0, T2, T3

Deliverers, referrers

To assess programme adherence and
attrition rates

Data on the overall adherence to the
programme, number of drops-outs and
reasons why

Quantitative
Qualitative

Data recorded
Deliverers (record data)
from the register
Stroke survivors
on weekly
attendance rates
for the 12 week
programme (stage
1) and 4 week
ambassador
programme (stage
2)
T2, T3

Data on the implementation outcomes will be collected from stroke survivors who have enrolled on the SO programme as well as the wider stakeholder group
involved in the SO programme (including deliverers, referrers and supports).
1
Adult Service Use Schedule (AD-SUS)
SO, Stroke Odysseys.

outcome (continuous, binary, ordinal). All analyses will
be conducted in STATA V.14.1.
Qualitative analysis
Initial analysis of qualitative data will be undertaken
using an inductive approach to thematic analysis. All data
from interviews and observations will be managed using
NVivo V.10 and examined to categorise themes and key
issues that emerge. Using this inductive approach, tentative theoretical explanations will be generated for each
subgroup. Summary memos for data sets will be developed for each subgroup to provide the basis for within

and between-group comparisons. The inductive approach
is data driven; based on observation, the early analysis
seeks to reveal patterns and themes from which tentative
hypothesis can be drawn subsequently leading to theory;
theories are devised to explain what is seen rather than
the other way around.
CFIR (www.CFIR.org) will be used to further guide the
coding and analysis (ie, framework analysis) of interview
data to identify barriers and facilitators to the implementation and sustainment of the SO programme. This
approach has been used previously, that is, CFIR has been
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Table 2 Implementation outcomes

Open access

Patient and public involvement
The programme has been developed and further refined
using codesign methodologies with a group of 20 members
of South London stroke communities. The project has
been shared widely with stroke clinicians across London
and has their full support. During the pandemic Rosetta
Life set up an advisory group consisting of Stroke Ambassadors to support the redesign of the website www.strokeodysseys.org, to monitor how people living with the effects
of a stroke were engaging with the online workshops, to
oversee the development of the education videos and the
Ambassadors Handbook.
This advisory group is now a stable and national network
of ambassadors who curate an online programme and
advise on the development and delivery of SO. They have
advised the investigators on the need to ensure that the
measures were aphasia friendly and found an organisation to make sure that the measures were aphasia friendly.
They will now look at the language of the Implementation
Science measures and make sure that they are accessible.
Trial registration and current status
This study is registered on ClinicalTrials.gov PRS under
the ClinicalTrials.gov. Recruitment was scheduled to start
in Autumn 2021.
Data protection
The investigator will ensure that this study is conducted
in full conformity with relevant regulations and with
the ICH Guidelines for Good Clinical Practice (CPMP/
ICH/135/95) July 1996. The investigator will ensure that
this study is conducted in accordance with the principles
of the Declaration of Helsinki.
Access to person identifiable implementation science
data will rest with the data custodian(s) from the immediate study team and the implementation science team.
Since the project seeks to explore in some depth participants’ experiences and barriers and facilitators to
implementation, it is important to maintain strict confidentiality and facilitate openness in the interviews and
survey responses, thus optimal data quality.
Consent forms and audio/video recordings will be kept
electronically in KCL’s SharePoint for the duration of
the study, only accessible by the teams at KCL, Kingston
University and Rosetta Life involved in the study. Consent
forms and other identifiable paperwork will be kept in
8

locked cabinets only accessible to the study team. Study
data will be kept in a separate location from the person
identifiable information. Access to the deidentified
research data will be shared with the study management
group for the purposes of review, analysis and dissemination. Only deidentified data will be analysed.
After the completion of the study, the study data will be
kept for the King’s College London’s standard retention
period of 10 years after the completion of the study. The
study data that support published results will be deposited in a secure data repository (eg, King’s Research
Data Management System). This will allow the data to be
accessible for future reuse as per King’s College London’s
policy on the management of research data long-term.
ETHICS AND DISSEMINATION
Ethical approval has been granted by the King’s College
London PNM Research Ethics Panel, REC reference:
LRS/DP-20/21–21549. Informed consent will be collected
in writing from all research participants and stakeholders
involved in the study. Findings will be published in peer-
reviewed journals and disseminated at national and international meetings.
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applied postimplementation to investigate facilitators and
barriers to implementation among stakeholders who had
already adopted and implemented an innovation, thus
identifying determinants of implementation posthoc.26 27
Reflective summaries: the relationship of the
researcher(s) with the research context they are investigating will be presented in the form of a written narrative
of ideas and experiences during data collection. These
reflective summaries will be shared with the research
team and externally to judge any possible biases with the
way the data were collected or prior assumptions.
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